As of 2025-07-11, the Relative Valuation of Jazz Pharmaceuticals PLC (JAZZ) is 160.00 USD. This relative valuation is based on P/E multiples. With the latest stock price at 112.48 USD, the upside of Jazz Pharmaceuticals PLC based on Relative Valuation is 42.2%.
The range of the Relative Valuation is 89.95 - 234.72 USD.
| Range | Selected | |
| Trailing P/E multiples | 21.5x - 30.0x | 27.5x |
| Forward P/E multiples | 18.9x - 23.5x | 22.0x |
| Fair Price | 89.95 - 234.72 | 160.00 |
| Upside | -20.0% - 108.7% | 42.2% |
| Date | P/E |
| 2025-07-10 | 14.38 |
| 2025-07-09 | 14.26 |
| 2025-07-08 | 13.95 |
| 2025-07-07 | 13.75 |
| 2025-07-03 | 13.99 |
| 2025-07-02 | 14.05 |
| 2025-07-01 | 13.99 |
| 2025-06-30 | 13.56 |
| 2025-06-27 | 13.66 |
| 2025-06-26 | 13.74 |
| 2025-06-25 | 13.69 |
| 2025-06-24 | 13.82 |
| 2025-06-23 | 13.65 |
| 2025-06-20 | 13.74 |
| 2025-06-18 | 13.83 |
| 2025-06-17 | 13.68 |
| 2025-06-16 | 14.01 |
| 2025-06-13 | 13.87 |
| 2025-06-12 | 14.10 |
| 2025-06-11 | 14.12 |
| 2025-06-10 | 14.44 |
| 2025-06-09 | 14.30 |
| 2025-06-06 | 14.20 |
| 2025-06-05 | 13.91 |
| 2025-06-04 | 13.99 |
| 2025-06-03 | 14.10 |
| 2025-06-02 | 13.84 |
| 2025-05-30 | 13.81 |
| 2025-05-29 | 13.84 |
| 2025-05-28 | 13.68 |
| 2025-05-27 | 13.99 |
| 2025-05-23 | 13.81 |
| 2025-05-22 | 13.78 |
| 2025-05-21 | 13.84 |
| 2025-05-20 | 14.19 |
| 2025-05-19 | 14.03 |
| 2025-05-16 | 13.93 |
| 2025-05-15 | 13.56 |
| 2025-05-14 | 13.62 |
| 2025-05-13 | 13.15 |
| 2025-05-12 | 13.24 |
| 2025-05-09 | 12.50 |
| 2025-05-08 | 12.58 |
| 2025-05-07 | 12.97 |
| 2025-05-06 | 14.21 |
| 2025-05-05 | 15.11 |
| 2025-05-02 | 15.34 |
| 2025-05-01 | 14.98 |
| 2025-04-30 | 14.95 |
| 2025-04-29 | 14.88 |